Includes 1 Hour Windows Media Video File and PowerPoint presentations for immediate download.
As pharmaceutical and biotech companies continue to build advantageous, innovative relationships with advocacy organizations, ensuring compliant interaction during collaboration is a continued challenge, given the evolving regulatory and compliance frameworks. Advocacy executives are faced with multiple compliance concerns from off-label use of therapies and the promotion of products to navigating interest areas and defining the scope of patient groups. Ensuring advocacy professionals have a thorough understanding of compliant boundaries starts with proper education and relationships that are clearly defined.
- Working with legal/compliance teams to ensure compliance procedures
- Training to have compliant conversations when working with PAGs
- Defining compliant relationships and conversations
- Best practices in defining compliant patient group collaboration
Vice President, Business Communications and Stakeholder Engagement